Pre-Clinical Study
Scientific Rigor for Early-Stage Research
At InventaLife, our Pre-Clinical Study services form the critical foundation for drug, nutraceutical, and Ayurvedic product development. We offer comprehensive, reliable, and regulatory-compliant in-vitro and in-vivo studies to evaluate the safety, efficacy, and pharmacological potential of new compounds before they enter human trials.
Our pre-clinical team combines scientific precision with strict adherence to GLP (Good Laboratory Practices) to ensure that all data generated is accurate, reproducible, and ready for submission in Investigational New Drug (IND) applications or regulatory filings. Whether your goal is to assess toxicity, understand the mechanism of action, or evaluate bioavailability, we tailor our studies to meet the unique requirements of your product and its intended market.
Our Pre-Clinical Capabilities Include
- Animal Model Studies (in-vivo): Disease-specific and exploratory models to study therapeutic effects, dosing, and toxicity profiles.
- Cellular and Molecular Assays (in-vitro): Screening, cytotoxicity, and mechanism-based assays using validated laboratory techniques.
- Toxicology and Pharmacology Studies: Acute, sub-chronic, chronic toxicity, genotoxicity, and safety pharmacology assessments.
- DMPK (Drug Metabolism and Pharmacokinetics): ADME profiling, bioavailability, and half-life analysis for informed clinical planning.
- GLP-Compliant Reports: Structured documentation for regulatory submissions, audits, and international filings.
With a focus on scientific excellence, regulatory readiness, and customized study design, InventaLife ensures that your product enters the clinical phase with confidence and clarity.
Let us support your early-stage research with data you can trust—and science that drives decisions.